Tirzepatide reconstitution videos: what TikTok gets wrong

What did @peptea_co actually say?

Bluntly: nothing. The transcript is a garbled rendition of "That's Amore," the Dean Martin classic, with no actual information about tirzepatide reconstitution anywhere in it. Phrases like "tippy tippy tippy tippy like a gate out until loud" and "tinglinglinglinglingling" are not reconstitution instructions. They are lyrics, or something adjacent to lyrics, captured by an auto-transcription tool that was clearly struggling.

The caption and hashtags promise a how-to on reconstituting tirzepatide. The audio delivered a song. Whether this was a transcription failure, a dubbed-over video, or a creator who forgot to actually explain anything on camera, the result is the same: zero instructional content was captured in the transcript we reviewed. We cannot fact-check claims that were never made.

Does the science back this up?

There is no scientific claim in this transcript to evaluate. That said, the topic the video was supposed to address, tirzepatide reconstitution, does have a real evidence base worth understanding. Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is not a traditional peptide in the research peptide sense.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide at 15 mg weekly produced mean body weight reductions of up to 22.5% over 72 weeks in adults with obesity. That is a meaningful clinical result. However, tirzepatide as used in that trial was the FDA-approved Mounjaro formulation, not a compounded or reconstituted product. Compounded tirzepatide exists in a separate regulatory category and cannot be assumed to perform identically to the approved drug.

What did they get wrong (or right)?

There is nothing to credit or correct in the transcript itself because the transcript contains no claims. What we can say is that the framing is problematic. Grouping tirzepatide under a "peptide" category alongside BPC-157 or TB-500 is misleading by implication. Tirzepatide is an approved pharmaceutical with a defined regulatory status, not a research peptide operating in the same grey-market space as growth hormone secretagogues.

If a viewer came to this video expecting to learn how to safely reconstitute a lyophilized compound, they left with nothing useful, and possibly a false sense that reconstitution is simple enough to be covered in a song. Reconstitution involves sterile bacteriostatic water, specific volume calculations, proper storage temperatures, and aseptic technique. None of that appeared here. That is a real gap, not a minor one.

What should you actually know?

If you are working with any reconstituted injectable compound, the process matters and errors carry real risk. Contamination, incorrect concentration math, and improper storage are the main failure points. A video that skips all of that in favor of Dean Martin is not a substitute for proper guidance from a licensed provider.

Tirzepatide specifically is only legally available in the US as FDA-approved Mounjaro or Zepbound, or through licensed compounding pharmacies operating under specific FDA enforcement policies that have shifted over time. The FDA issued guidance in 2024 clarifying conditions under which compounded tirzepatide could be dispensed during shortage periods. Patients and providers should verify current regulatory status before use. No reconstitution tutorial from a social media account replaces a clinical consultation.

• Always source reconstitution guidance from your prescribing provider or licensed pharmacist.
• Bacteriostatic water, not sterile water, is the standard diluent for most reconstituted peptides.
• Storage temperature and light exposure affect peptide stability significantly after reconstitution.